Medical Radiology and Radiation Safety. 2025. Vol. 70. № 6
DOI:10.33266/1024-6177-2025-70-6-54-58
A.R. Tukov, M.N. Ziyatdinov, O.N. Prochorova, A.M. Mihajlenko, M.G. Archegova
Incidence of Chernobyl Accident Liquidators, Employees of enterprises and Organizations Served by Healthcare Institutions of the FMBA of Russia, Goiter (Endemic) Associated with Iodine Deficiency, Unspecified
A.I. Burnazyan Federal Medical Biophysical Center, Moscow, Russia
Contact person: M.N. Ziyatdinov, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
ABSTRACT
Purpose: To assess the incidence of goiter (endemic) associated with iodine deficiency (ICD 10; E01.2) among liquidators of the consequences of the Chernobyl accident, employees of enterprises and organizations served by healthcare institutions of the Federal Medical and Biological Agency of Russia.
Material and methods: The work uses the information base of the Industry Register of Persons Exposed to Radiation as a Result of the Chernobyl Accident (IRRA), developed by the A.I. Burnazyan Federal Medical Biophysical Center of the Federal Medical and Biological Agency of Russia and containing information on newly identified thyroid diseases associated with iodine deficiency (ICD 10; E01.2). The registry database contains information on 8469 diagnoses of endocrine diseases, eating disorders and metabolic disorders (ICD 10; E00‒E90.9), identified for the first time, men ‒ 6678 (78.9 %), women ‒ 1791 (21.1 %), liquidators of the consequences of the Chernobyl accident, employees of enterprises and organizations served by healthcare institutions of the Federal Medical and Biological Agency of Russia.
The statistical software package Excel was used to process the research results. Original programs were developed to calculate absolute and intensive indicators and the growth rate. The incidence of goiter (endemic) associated with iodine deficiency (ICD 10; E01.2) was calculated per 1000 workers.
Results: The incidence of goiter (endemic) associated with iodine deficiency (ICD 10; E01.2) among workers of enterprises and organizations served by healthcare institutions of the Federal Medical and Biological Agency of Russia was assessed. The features of the structure of registered diseases in this contingent were established. The dynamics of the incidence of goiter (endemic) associated with iodine deficiency (ICD 10; E01.2) for this nosology for the period 1989‒2023 was assessed.
Conclusion: In the structure of newly diagnosed diseases of the endocrine system, nutritional disorders and metabolic disorders (ICD 10; E00‒E90.9) in male liquidators of the consequences of the Chernobyl accident, the first place in the ranking is occupied by goiter (endemic), associated with iodine deficiency, unspecified (ICD 10; E01.2) ‒ 14.3 %. In women, goiter (endemic), associated with iodine deficiency, unspecified (ICD 10; E01.2) occupies the third place in the ranking ‒ 10.7 %. The dynamics of the epidemiological process of goiter (endemic), associated with iodine deficiency, unspecified (ICD 10; E01.2) shows that this nosology affects workers of a younger age (the incidence of men aged 18–29 was 11.2 ± 1.3, 70 years and older ‒ 0.1 ± 0.1; women ‒ 18‒29 years was 10.3 ± 2.9, 70 years and older ‒ 0.1 ± 0.1. The aging of the contingent determined a negative growth rate both in men = ‒48.93 % and in women = ‒52.58 %.
Keywords: accident, Chernobyl Nuclear Power Plant, liquidators, morbidity, goiter endemic, iodine deficiency
For citation: Tukov AR, Ziyatdinov MN, Prochorova ON, Mihajlenko AM, Archegova MG. Incidence of Chernobyl Accident Liquidators, Employees of enterprises and Organizations Served by Healthcare Institutions of the FMBA of Russia, Goiter (Endemic) Associated with Iodine Deficiency, Unspecified. Medical Radiology and Radiation Safety. 2025;70(6):54–58. (In Russian). DOI:10.33266/1024-6177-2025-70-6-54-58
References
1. Трошина Е.А., ПлатоноваН.М., ПанфиловаЕ.А. Динамика эпидемиологических показателей тиреоидной патологии у населения Российской Федерации: аналитический отчет за период 2009-2018 гг // Проблемы Эндокринологии. 2021. Т.67. №2. С. 10-19 [Troshina Ye.A., Platonova N.M., Panfilova Ye.A. Dynamics of Epidemiological Indicators of thyroid Pathology in the Population of the Russian Federation: Analytical Report for the Period 2009-2018. Problemy Endokrinologii = Problems of Endocrinology. 2021;67;2:10-19 (In Russ.)] doi: 10.14341/probl12433.
2. Eastman C.J. Screening for Thyroid Disease and Iodine Deficiency. Pathology. 2012 Feb;44;2:153-9. doi: 10.1097/PAT.0b013e32834e8e83. PMID: 22297907.
3. Andersson M., Braegger C.P. The Role of Iodine for Thyroid Function in Lactating Women and Infants. Endocr Rev. 2022 May 12;43;3:469-506. doi: 10.1210/endrev/bnab029.
4. Taylor P.N., Medici M.M., Hubalewska-Dydejczyk A., Boelaert K. Hypothyroidism. Lancet. 2024 Oct 5;404;10460:1347-1364. doi: 10.1016/S0140-6736(24)01614-3.
3. Роспотребнадзор. Диффузный (эндемический) зоб, связанный с йодной недостаточностью (E01.0). Электронный ресурс: https://diseases.medelement.com/disease/ -e01-0/2010. [Rospotrebnadzor. Diffuznyy (Endemicheskiy) Zob, Svyazannyy s Yodnoy Nedostatochnost’yu (E01.0) = Diffuse (Endemic) Goiter Associated with Iodine Deficiency (E01.0). URL: https://diseases.medelement.com/disease/ -e01-0/2010 (In Russ.)].
4. Абдулхабирова Ф.М., Безлепкина О.Б., Бровин Д.Н., Вадина Т.A., Мельниченко Г.А., Нагаева Е.В., Никанкина Л.В., Петеркова В.А., Платонова Н.М., Рыбакова А.А., Солдатова Т.В., Трошина Е.А., Ширяева Т.Ю. Клинические рекомендации «Заболевания и состояния, связанные с дефицитом йода» // Проблемы Эндокринологии. 2021. Т.67. №3. С. 10-25 [Abdulkhabirova F.M., Bezlepkina O.B., Brovin D.N., Vadina T.A., Mel’nichenko G.A., Nagayeva Ye.V., Nikankina L.V., Peterkova V.A., Platonova N.M., Rybakova A.A., Soldatova T.V., Troshina Ye.A., Shiryayeva T.Yu. Clinical Guidelines “Diseases and Conditions Associated with Iodine Deficiency”. Problemy Endokrinologii = Problems of Endocrinology. 2021;67;3:10-25 (In Russ.)]. doi: 10.14341/probl12750.
5. Voulgari P.V., Venetsanopoulou A.I., Kalpourtzi N., Gavana M., Vantarakis A., Hadjichristodoulou C., Chlouverakis G., Trypsianis G., Alamanos Y., Touloumi G. EMENO Study Group. Thyroid Dysfunction in Greece. Results from the National Health Examination Survey EMENO. PLoS One. 2022 Mar 4;17;3:e0264388. doi: 10.1371/journal.pone.0264388.
6. Maldonado-Araque C., Valdés S., Badía-Guillén R., Lago-Sampedro A., Colomo N., Garcia-Fuentes E., Gutierrez-Repiso C., Goday A., Calle-Pascual A., Castaño L., Castell C., Delgado E., Menendez E., Franch-Nadal J., Gaztambide S., Girbés J., Chaves F.J., Soriguer F., Rojo-Martínez G. Iodine Deficiency and Mortality in Spanish Adults. This email address is being protected from spambots. You need JavaScript enabled to view it. Study. Thyroid. 2021 Jan;31;1:106-114. doi: 10.1089/thy.2020.0131.
7. Gaberšček S., Zaletel K. Epidemiological Trends of Iodine-Related thyroid Disorders: an Example from Slovenia. Arh Hig Rada Toksikol. 2016 Jun 1;67;2:93-8. doi: 10.1515/aiht-2016-67-2725. PMID: 27331296.
8. Zhang C., Gao X., Han Y., Teng W., Shan Z. Correlation between Thyroid Nodules and Metabolic Syndrome: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne). 2021 Sep 16;12:730279. doi: 10.3389/fendo.2021.730279.
9. Teti C., Panciroli M., Nazzari E., Pesce G., Mariotti S., Olivieri A., Bagnasco M. Iodoprophylaxis and Thyroid Autoimmunity: an Update. Immunol Res. 2021 Apr;69;2:129-138. doi: 10.1007/s12026-021-09192-6.
10. Pearce E.N., Zimmermann M.B. The Prevention of Iodine Deficiency: a History. Thyroid. 2023 Feb;33;2:143-149. doi: 10.1089/thy.2022.0454.
11. Riis J., Pedersen K.M., Danielsen M.B., Sørensen G.V.B., Jørgensen M.G., Andersen S.L., Carlé A., Pedersen I.B., Torp-Pedersen C., Andersen S. Long-Term Iodine Nutrition is Associated with Longevity in older Adults: a 20 years’ Follow-Up of the Randers-Skagen Study. Br J Nutr. 2021 Feb 14;125;3:260-265. doi: 10.1017/S0007114520001592.
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The study had no sponsorship.
Contribution. Article was prepared with equal participation of the authors.
Article received: 20.07.2025. Accepted for publication: 25.08.2025.